Sangeeta Bhatia is an MIT Professor, entrepreneur, and advocate for diversity. Her laboratory focuses on the intersection of engineering, medicine, and biology to create innovative platforms for understanding, diagnosing, and treating human diseases. Her research spans from developing tools for cancer diagnostics and precision therapeutics to engineering human microlivers for drug metabolism, liver disease, and infection modeling. With a background in both medicine and engineering, Bhatia has made significant contributions to the field, including over 50 patents and the launch of multiple biotechnology companies. She is recognized for her achievements with prestigious awards and memberships in all three US National Academies. Additionally, she serves on boards and advisory roles for various organizations in the medical and biotech fields.